You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 14, October 10, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (1)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Substance Abuse/ Alcoholism
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Medications to Treat Alcohol Dependence

Adding to the Continuum of Care

Mark L. Willenbring, MD

JAMA. 2007;298:1691-1692.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The most prevalent form of treatment for alcohol dependence in the United States is group counseling and referral to community support groups, a treatment that was developed more than 30 years ago.1 At that time, the only medication available to prevent relapse was disulfiram, which has limited efficacy and patient acceptability. Since that time, acamprosate and naltrexone have been approved for the treatment of alcohol dependence, the latter in both oral and long-acting injectible forms. However, few physicians prescribe these drugs, and most treatment programs do not use them.2

In this issue of JAMA, Johnson and colleagues3 report on a large multisite trial of topiramate, a drug with complex actions including activity at {gamma}-aminobutyric acid and glutamate receptors. Replicating the results of a smaller randomized controlled trial,4 topiramate produced significant and meaningful improvement in a wide variety of drinking outcomes. At the end of the . . . [Full Text of this Article]

Author Affiliation: National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED LETTER

Topiramate as Treatment for Alcohol Dependence
Sarah Stringer, Marie Rueve, and Douglas Mossman
JAMA. 2008;299(4):405-406.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Topiramate for Treating Alcohol Dependence: A Randomized Controlled Trial
Bankole A. Johnson, Norman Rosenthal, Julie A. Capece, Frank Wiegand, Lian Mao, Karen Beyers, Amy McKay, Nassima Ait-Daoud, Raymond F. Anton, Domenic A. Ciraulo, Henry R. Kranzler, Karl Mann, Stephanie S. O’Malley, Robert M. Swift, and for the Topiramate for Alcoholism Advisory Board and the Topiramate for Alcoholism Study Group
JAMA. 2007;298(14):1641-1651.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Topiramate for Alcohol Dependence
Olmsted and Kockler
The Annals of Pharmacotherapy 2008;42:1475-1480.
ABSTRACT | FULL TEXT  

Topiramate as Treatment for Alcohol Dependence
Stringer et al.
JAMA 2008;299:405-406.
FULL TEXT  

Topiramate and Alcohol Dependence
JWatch General 2007;2007:2-2.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.